Friday, August 7, 2020
The New Jersey Appellate Division reinstated two suits linking Johnson & Johnson's talc products to ovarian cancer. A trial judge had disqualified the plaintiffs' experts in those cases based on a 2018 ruling in an Accutane case. The Appellate Division, however, found that the judge substituted his own opinions of the experts' arguments for the scientific community's. The ruling ends a multi-year stay on around 800 similar suits in Atlantic County. Charles Toutant of the New Jersey Law Journal, via George Conk, has the story.